insights on clinical AI, guideline access, and the future of medicine
See objective, head-to-head comparisons of iatroX against other clinical tools.
The MRCGP AKT has changed. From October 2025, the exam moved to 160 questions in 160 minutes. This guide explains what the new format means for your revision strategy, offering an ...
Read Insight
From September 2025, the PANE became the PARA (Physician Associate Registration Assessment). This guide explains what has changed (the name and governance) and what hasn't (the KBA...
Read Insight
The PANE is now the PARA. This 2025 guide for UK Physician Associates breaks down the new Registration Assessment format (KBA + 14-station OSCE) delivered by the RCP. We provide a ...
Read Insight
A 2026 deep dive into the Ubie AI Symptom Checker for UK clinicians. We analyse Ubie's strong transparency on data sources and editorial policy, its evidence base, and how to manag...
Read Insight
Is K Health the "ChatGPT for doctors"? This 2026 review for UK clinicians unpacks the "AI Physician Mode" study, explains why the US-centric model doesn't fit NHS practice, and hig...
Read Insight
A practical guide for UK GPs on the Buoy Health symptom checker. We explain what Buoy does, why its US-centric advice can misalign with NHS pathways, and how to manage patients who...
Read Insight
A 2026 review of the Symptoma symptom checker for UK GPs. We explain how its "probability-ranked" engine works, what the evidence says about its accuracy compared to tools like Ada...
Read Insight
A 2026 review of Infermedica's virtual triage engine for the NHS. We explain the difference between patient-facing triage AI and clinician-facing reference tools. Get a 12-point pr...
Read Insight
A 2026 review of the Ada Symptom Checker for UK GPs. We explore what Ada claims to do, the evidence behind symptom checker accuracy from journals like BMJ Open, and the regulatory ...
Read Insight
A 2026 review of Glass Health for UK clinicians. This article explores the promise of "ambient clinical intelligence" for drafting notes and differentials, and the critical safety ...
Read Insight
Dermatology is a "risk hotspot" for UK GPs. This 2026 review explores how VisualDx acts as a powerful visual decision support tool to de-risk rashes and drug eruptions. We outline ...
Read Insight
A 2026 review of the Isabel DDx Companion for UK GPs. This guide explores when to use Isabel for expanding your differential diagnosis versus when to rely on NICE CKS for managemen...
Read Insight